"Why do you ask my opinion, in that case?"
There is a need for posters here to challenge most of your posts, as they come across as astute but are almost always made with a negative undertone.
For somebody who always says they want to see Mesoblast start generating revenue so they can be a shareholder, you don't seem the least interested in the fact that they have found a means to fund the pediatric aGVHD program to launch in 2019?
With the phase 3 FDA trial primary endpoints achieved, with fast-track designation and no alternative approved product to treat pediatric aGVHD in the US... would you not see it as a cop-out if we went with a partner and gave up half the future cash flows for this program? Best case we would get US$50m upfront cash ... best case.
Yet you were suggesting they should take a partnership for their pediatric aGVHD program... so I can only assume you believe that is a great outcome for shareholders (US$50m upfront, 50% royalty)?
Add to My Watchlist
What is My Watchlist?
